Corofenam is a next-generation oral β-lactam antibiotic formulated with Faropenem Sodium 200 mg, designed to treat a wide range of bacterial infections effectively and safely. It delivers potent activity against Gram-positive, Gram-negative, aerobic, and anaerobic pathogens, making it ideal for managing both uncomplicated and resistant infections. With its low-dose, high-efficacy profile, Corofenam ensures strong antibacterial action with minimal adverse effects, providing a convenient alternative to injectable carbapenems.
Composition
Indications
Corofenam is indicated for the treatment of:
-
Urinary Tract Infections (UTI)
-
Upper and Lower Respiratory Tract Infections
-
Skin and Soft Tissue Infections
-
Gynecological Infections
-
Infections caused by drug-resistant Gram-positive or Gram-negative bacteria
Dosage
-
5–10 mg/kg body weight, administered orally every 12 hours
-
Dosage may be adjusted as per the severity of infection and physician’s discretion
Scientific Insights
1. Broad-Spectrum Activity
Faropenem, a β-lactam antibiotic, exhibits powerful antibacterial activity against both aerobic and anaerobic, Gram-positive and Gram-negative bacteria. Its broad-spectrum nature makes it suitable for empirical therapy in suspected resistant infections.
2. Potent Efficacy at Lower Doses
Compared to injectable carbapenems like meropenem (typically dosed at 12–24 mg/kg), Faropenem in Corofenam achieves similar or superior results at just 5–10 mg/kg, reducing potential toxicity and improving patient safety.
3. Oral Convenience & Enhanced Compliance
Orally administered Corofenam simplifies treatment regimens, reduces the need for hospitalization, and improves patient adherence in outpatient or home-based care.
4. Safety Profile
Corofenam is well tolerated, with minimal gastrointestinal side effects such as nausea or diarrhea. Its precise formulation ensures better absorption and lower systemic toxicity, even during prolonged use.
Corofenam – Trusted by Physicians for Reliable, Safe, and Effective Infection Control
A practical solution for frontline infection management in general and resistant bacterial infections.
